{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:53:48Z","timestamp":1790873628843,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13482-5","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T07:43:58Z","timestamp":1779090238000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence and genotype distribution of human papillomavirus (HPV) in an at-risk and suspected population in Iran"],"prefix":"10.1186","volume":"26","author":[{"given":"Shaghayegh","family":"Hossein zadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi","family":"Habibnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Rokni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"issue":"11","key":"13482_CR1","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/S1473-3099(20)30860-4","volume":"21","author":"M Drolet","year":"2021","unstructured":"Drolet M, Laprise JF, Martin D, Jit M, B\u00e9nard \u00c9, Gingras G, et al. Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis. Lancet Infect Dis. 2021;21(11):1598\u2013610. PubMed PMID: 34245682. Pubmed Central PMCID: PMC8554391. Epub 20210707. eng.","journal-title":"Lancet Infect Dis"},{"key":"13482_CR2","doi-asserted-by":"crossref","unstructured":"Makadzange EE, Peeters A, Joore MA, Kimman ML. The effectiveness of health education interventions on cervical cancer prevention in Africa: a systematic review. Prev Med. 2022;164:107219.","DOI":"10.1016\/j.ypmed.2022.107219"},{"issue":"2","key":"13482_CR3","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","volume":"8","author":"M Arbyn","year":"2020","unstructured":"Arbyn M, Weiderpass E, Bruni L, de Sanjos\u00e9 S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191\u2013203. PubMed PMID: 31812369. Pubmed Central PMCID: PMC7025157. Epub 20191204. eng.","journal-title":"Lancet Glob Health"},{"key":"13482_CR4","doi-asserted-by":"crossref","unstructured":"Chan CK, Aimagambetova G, Ukybassova T, Kongrtay K, Azizan A. Human papillomavirus infection and cervical cancer: epidemiology, screening, and vaccination\u2014review of current perspectives. J Oncol. 2019;2019:3257939. PMCID: PMC6811952.","DOI":"10.1155\/2019\/3257939"},{"key":"13482_CR5","doi-asserted-by":"crossref","unstructured":"Luvi\u00e1n-Morales J, Guti\u00e9rrez-Enr\u00edquez SO, Granados-Garc\u00eda V, Torres-Poveda K. Risk factors for the development of cervical cancer: analysis of the evidence. Front Oncol. 2024;14:1378549. Epub 2024 Jun 7. PubMed PMID: 38846977; PMCID: PMC11153748.","DOI":"10.3389\/fonc.2024.1378549"},{"issue":"5","key":"13482_CR6","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S1473-3099(14)71073-4","volume":"15","author":"M Drolet","year":"2015","unstructured":"Drolet M, B\u00e9nard \u00c9, Boily MC, Ali H, Baandrup L, Bauer H, et al. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis. 2015;15(5):565\u201380. PubMed PMID: 25744474. Pubmed Central PMCID: PMC5144106. Epub 20150303. eng.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"13482_CR7","doi-asserted-by":"publisher","first-page":"e0210311","DOI":"10.1371\/journal.pone.0210311","volume":"14","author":"L Jiang","year":"2019","unstructured":"Jiang L, Tian X, Peng D, Zhang L, Xie F, Bi C, et al. HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong\u2019s largest independent pathology laboratory. PLoS ONE. 2019;14(1):e0210311. PubMed PMID: 30653566. Pubmed Central PMCID: PMC6336302. Epub 20190117. eng.","journal-title":"PLoS ONE"},{"issue":"4","key":"13482_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","volume":"10","author":"V Bouvard","year":"2009","unstructured":"Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al. A review of human carcinogens\u2013Part B: biological agents. Lancet Oncol. 2009;10(4):321\u20132. PubMed PMID: 19350698. eng.","journal-title":"Lancet Oncol"},{"issue":"7","key":"13482_CR9","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1002\/jmv.27706","volume":"94","author":"M Vazifehdoost","year":"2022","unstructured":"Vazifehdoost M, Eskandari F, Sohrabi A. Trends in cocirculation of oncogenic HPV genotypes in single and multiple infections among the unvaccinated community. J Med Virol. 2022;94(7):3376\u201385.","journal-title":"J Med Virol"},{"issue":"3","key":"13482_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1051\/bmdcn\/2018080318","volume":"8","author":"Z Momenimovahed","year":"2018","unstructured":"Momenimovahed Z, Salehiniya H. Cervical cancer in Iran: integrative insights of epidemiological analysis. Biomed (Taipei). 2018;8(3):18. PubMed PMID: 30141405. Pubmed Central PMCID: PMC6108227. Epub 2018\/08\/25. eng.","journal-title":"Biomed (Taipei)"},{"key":"13482_CR11","doi-asserted-by":"crossref","unstructured":"Mobini Kesheh M, Keyvani H. The prevalence of HPV genotypes in Iranian population: an update. Iran J Pathol. 2019;14(3):197\u2013205. Epub 2019 Oct 5. PubMed PMID: 31582996; PMCID: PMC6742734.","DOI":"10.30699\/IJP.2019.90356.1861"},{"key":"13482_CR12","doi-asserted-by":"crossref","unstructured":"Sabet F, Mosavat A, Ahmadi Ghezeldasht S, Basharkhah S, Shamsian SAA, Abbasnia S, et al. Prevalence, genotypes and phylogenetic analysis of human papillomaviruses (HPV) in northeast Iran. Int J Infect Dis. 2021 2021\/02\/01\/;103:480\u20138.","DOI":"10.1016\/j.ijid.2020.12.015"},{"issue":"1","key":"13482_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1071\/SH12056","volume":"10","author":"EK Waters","year":"2013","unstructured":"Waters EK, Hamilton AJ, Smith AM, Philp DJ, Donovan B, Regan DG. Fixed sized samples for type-specific surveillance of human papillomavirus in genital warts. Sex Health. 2013;10(1):95\u201396. Epub 2012 Nov 20. PubMed PMID: 23158539.","journal-title":"Sex Health"},{"key":"13482_CR14","doi-asserted-by":"crossref","unstructured":"Smith JHF. Bethesda 2001. Cytopathology. 2002;13(1):4\u201310.","DOI":"10.1046\/j.1365-2303.2002.00397.x"},{"issue":"3","key":"13482_CR15","first-page":"56","volume":"3","author":"J Rakotozafy","year":"2013","unstructured":"Rakotozafy J, Ratiarson A. Prevalence and associated factors to human papillomavirus types 16 and 18 among Malagasy women in Fianarantsoa, Madagascar. Clin Med Diagnostics. 2013;3(3):56\u201360.","journal-title":"Clin Med Diagnostics"},{"issue":"6","key":"13482_CR16","doi-asserted-by":"publisher","first-page":"660","DOI":"10.6004\/jnccn.2020.0027","volume":"18","author":"NR Abu-Rustum","year":"2020","unstructured":"Abu-Rustum NR, Yashar CM, Bean S, Bradley K, Campos SM, Chon HS, et al. NCCN guidelines insights: cervical cancer, version 1.2020: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2020;18(6):660\u20136.","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"13482_CR17","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.3802\/jgo.2016.27.e21","volume":"27","author":"YJ Choi","year":"2016","unstructured":"Choi YJ, Park JS. Clinical significance of human papillomavirus genotyping. J Gynecol Oncol. 2016;27(2):e21.","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"13482_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-015-0437-9","volume":"13","author":"M Bissa","year":"2015","unstructured":"Bissa M, Illiano E, Pacchioni S, Paolini F, Zanotto C, De Giuli Morghen C, et al. A prime\/boost strategy using DNA\/fowlpox recombinants expressing the genetically attenuated E6 protein as a putative vaccine against HPV-16-associated cancers. J translational Med. 2015;13(1):1\u201312.","journal-title":"J translational Med"},{"issue":"11","key":"13482_CR19","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.25122\/jml-2022-0031","volume":"15","author":"M Hashemnejad","year":"2022","unstructured":"Hashemnejad M, Mirmajidi R, Rahimzadeh M, Ataei M. The prevalence of high-risk human papillomavirus genotypes and related risk factors among Iranian women. J Med Life. 2022;15(11):1340\u20136. PubMed PMID: 36567834. Pubmed Central PMCID: PMC9762374. eng.","journal-title":"J Med Life"},{"issue":"8","key":"13482_CR20","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.1002\/jmv.26928","volume":"93","author":"Z Salavatiha","year":"2021","unstructured":"Salavatiha Z, Farahmand M, Shoja Z, Jalilvand S. A meta-analysis of human papillomavirus prevalence and types among Iranian women with normal cervical cytology, premalignant lesions, and cervical cancer. J Med Virol. 2021;93(8):4647\u201358. PubMed PMID: 33694179. Epub 20210326. eng.","journal-title":"J Med Virol"},{"key":"13482_CR21","doi-asserted-by":"crossref","unstructured":"Kombe Kombe AJ, Li B, Zahid A, Mengist HM, Bounda GA, Zhou Y, et al. Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation. Front Public Health. 2020;8:552028. Epub 2021 Jan 20. PubMed PMID: 33553082; PMCID: PMC7855977.","DOI":"10.3389\/fpubh.2020.552028"},{"issue":"1","key":"13482_CR22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13104-018-3241-9","volume":"11","author":"N Phoolcharoen","year":"2018","unstructured":"Phoolcharoen N, Kantathavorn N, Krisorakun W, Sricharunrat T, Teerayathanakul N, Taepisitpong C, et al. Agreement of self- and physician-collected samples for detection of high-risk human papillomavirus infections in women attending a colposcopy clinic in Thailand. BMC Res Notes. 2018;11(1):136. PubMed PMID: 29458440. Pubmed Central PMCID: PMC5819229. Epub 20180220. eng.","journal-title":"BMC Res Notes"},{"key":"13482_CR23","doi-asserted-by":"crossref","unstructured":"Verrier F, Le Coeur S, Delory T. Cervical human papillomavirus infection (HPV) and high oncogenic risk genotypes among women living with HIV in Asia: a meta-analysis. J Clin Med. 2021;10(9). Epub 2021 Apr 28. PubMed PMID: 33924989; PMCID: PMC8125216.","DOI":"10.3390\/jcm10091911"},{"key":"13482_CR24","doi-asserted-by":"crossref","unstructured":"Aghakhani A, Mamishi S, Sabeti S, Bidari-Zerehpoosh F, Banifazl M, Bavand A, et al. Gender- and age-specific seroprevalence of human papillomavirus 16 and 18 in the general population in Tehran, Iran. Med Microbiol Immunol. 2017;206(2):105\u2013110.","DOI":"10.1007\/s00430-016-0487-5"},{"issue":"2","key":"13482_CR25","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/jmv.24053","volume":"87","author":"S Jalilvand","year":"2015","unstructured":"Jalilvand S, Shoja Z, Nourijelyani K, Tohidi HR, Hamkar R. Meta-analysis of type-specific human papillomavirus prevalence in Iranian women with normal cytology, precancerous cervical lesions and invasive cervical cancer: Implications for screening and vaccination. J Med Virol. 2015;87(2):287\u201395. PubMed PMID: 25156655. Epub 20140825. eng.","journal-title":"J Med Virol"},{"key":"13482_CR26","doi-asserted-by":"crossref","unstructured":"Ji J, Sun HK, Smith JS, Wang H, Esser MT, Hu S, et al. Seroprevalence of human papillomavirus types 6, 11, 16 and 18 in Chinese women. BMC Infect Dis. 2012;12:137. Epub 2012 Jun 20. PubMed PMID: 22715915; PMCID: PMC3482566.","DOI":"10.1186\/1471-2334-12-137"},{"issue":"3","key":"13482_CR27","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/ijc.10825","volume":"103","author":"HR Shin","year":"2003","unstructured":"Shin HR, Lee DH, Herrero R, Smith JS, Vaccarella S, Hong SH, et al. Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer. 2003;103(3):413\u201321. PubMed PMID: 12471626. eng.","journal-title":"Int J Cancer"},{"issue":"2","key":"13482_CR28","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jcv.2006.12.004","volume":"38","author":"C-J Chen","year":"2007","unstructured":"Chen C-J, Viscidi RP, Chuang C-H, Huang Y-C, Chiu C-H, Lin T-Y. Seroprevalence of human papillomavirus types 16 and 18 in the general population in Taiwan: implication for optimal age of human papillomavirus vaccination. J Clin Virol. 2007;38(2):126\u201330.","journal-title":"J Clin Virol"},{"key":"13482_CR29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ejogrb.2025.03.001","volume":"308","author":"O Aynaud","year":"2025","unstructured":"Aynaud O, Huynh B, Bergeron C. Should men whose female partners have cervical high grade intraepithelial lesion (HSIL) be screened? Eur J Obstet Gynecol Reprod Biol. 2025;308:257\u201360. PubMed PMID: 40088546. Epub 2025\/03\/16. eng.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"13482_CR30","doi-asserted-by":"crossref","unstructured":"Kalvatchev Z, Draganov P, Gancheva A, Sayej M. Effective PCR systems for rapid identification of human papillomaviruses (HPVs). Biotechnol Biotechnol Equip. 2003;17(2):146\u2013150.","DOI":"10.1080\/13102818.2003.10817073"},{"key":"13482_CR31","doi-asserted-by":"crossref","unstructured":"Camargo M, Soto-De Leon S, Sanchez R, Munoz M, Vega E, Beltran M, et al. Detection by PCR of human papillomavirus in Colombia: comparison of GP5+\/6+ and MY09\/11 primer sets. J Virol Methods. 2011;178(1):68\u201374.","DOI":"10.1016\/j.jviromet.2011.08.014"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13482-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13482-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13482-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T15:01:51Z","timestamp":1783954911000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13482-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13482"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13482-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were by the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study protocol was approved by the ethics committee of the Islamic Azad University-Parand Branch (Ethical code: IR.IAU.PIAU.REC.1399.009), and written consent was taken from all subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1304"}}